tiprankstipranks
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
US Market

Adverum Biotechnologies (ADVM) Income Statement

Compare
602 Followers

Adverum Biotechnologies Income Statement

Last quarter (Q3 2024), Adverum Biotechnologies's total revenue was $1.00M, an increase of Infinity% from the same quarter last year. In Q3, Adverum Biotechnologies's net income was $-27.13M. See Adverum Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.60M$ 0.00$ 7.50M$ 0.00$ 250.00K
Gross Profit
$ -2.04M$ -6.53M$ 2.85M$ -4.16M$ 250.00K
Operating Expenses
$ 127.59M$ 157.13M$ 153.62M$ 117.95M$ 68.80M
Depreciation and Amortization
$ 5.64M$ 6.53M$ 4.64M$ 4.16M$ 1.57M
EBITDA
$ -118.35M$ -147.93M$ -140.90M$ -112.23M$ -62.91M
Operating Income
$ -123.99M$ -157.13M$ -146.12M$ -117.95M$ -68.55M
Other Income/Expenses
$ 5.75M$ 549.00K$ -481.00K$ 1.56M$ 4.06M
Pretax Income
$ -118.24M$ -154.46M$ -145.54M$ -116.39M$ -64.49M
Net Income
$ -117.17M$ -154.54M$ -145.54M$ -117.51M$ -64.49M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -11.62$ -15.57$ -14.85$ -13.80$ -10.06
Diluted EPS
$ -11.62$ -15.57$ -14.85$ -13.80$ -10.06
Weighted Average Shares Outstanding
10.08M 9.93M 9.80M 8.51M 6.41M
Weighted Average Shares Outstanding (Diluted)
10.08M 9.93M 9.80M 8.51M 6.41M
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis